Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

SOCRA 2024 > SOCRA 2024 > Flashcards

SOCRA 2024 Flashcards

1
Q

What is 21 CFR 11?

A

Electronic Records; Electronic Signatures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is 21 CFR 50?

A

Informed Consent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is 21 CFR 54?

A

Financial Disclosure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is 21 CFR 56?

A

Institutional Review Boards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is 21 CFR 312?

A

Investigational New Drug Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is 21 CFR 314?

A

New Drug Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is 21 CFR 812?

A

Investigational Device Exemption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is 21 CFR 814?

A

Premarket Approval of Medical Devices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is 45 CFR 46?

A

Federal Research
“The Common Rule”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What countries adhere to ICH E6 GCP?

A
  1. European Union
  2. Japan
  3. Unites States
  4. Australia
  5. Canada
  6. Nordic Countries
  7. World Health Organization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does ALCOA-C stand for?

A

Attributable, Legible, Contemporaneous, Original, Accurate, Complete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What year did the Nuremberg Code come out?

A

1947

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What foundation of ethical research come out during WWII?

A

The Nuremberg Code

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the core principle of the Nuremberg Code?

A

Informed Consent - Voluntary consent of the human subject is absolutely essential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who wrote the World Medical Association (WMA)?

A

The Declaration of Helsinki

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What year did The Belmont Report come out?

A

1974

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the three basic ethical principles of The Belmont Report?

A
  1. Respect for Persons
  2. Beneficence
  3. Justice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Respect for Persons (Belmont Report)?

A

Individuals should be treated as autonomous agents capable of deliberation about personal goals. This is all about respect for autonomy of the person.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Beneficence (Belmont Report)?

A

Persons are treated in an ethical manner not only for respecting their decisions and protecting them from harm, but also by making efforts to secure their well-being.

Example: do not harm, maximize possible benefits and minimize possible harms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is Justice (Belmont Report)?

A

Fairness in distribution of burdens and benefits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

who’s responsibility is it to obtain the signed 1572 (pharmaceutical investigation) or Investigator Agreement (device investigation)?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does the Investigator’s Agreement contain?

A
  1. CV
  2. Statement of Investigator’s relevant experience
  3. Explanation of termination circumstances
  4. Statement of the Investigator Commitment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Who can the Sponsor transfer any or all of their responsibilities to?

A

Contract Research Organization (CRO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Who is responsible for proper monitoring and providing a monitoring plan?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the DSMB and what do they do?

A

DSMB: Data Safety Monitoring Board

Independent group who conducts periodic review and evaluates study data for patient safety, study conduct and progress - will have initiated “event triggers” prior to study start.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Who is responsible for manufacturing, packaging, labeling and coding of the investigational product?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Who is responsible for providing the investigational product only to investigators participating in an investigation?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Who is responsible for maintaining drug and device accountability records from manufacturing through use, return and destruction?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Who is responsible for promptly reporting information about significant new adverse events, new information or risks with respect to the investigational product or investigations to the FDA and investigators?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

If the sponsor determines that the investigational product presents an unreasonable and significant risk to study subjects, the sponsor must do the following (3 things)?

A
  1. Discontinue all studies that present the risk
  2. Notify FDA, all investigators involved in the study(ies) and their IRBs
  3. Assure return and accounting for all investigational product, its return to the sponsor (or on-site destruction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Who is responsible to submit Safety Reports (Expedited Reporting), if appropriate?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

32
Q

Who is responsible for providing pre-clinical and clinical study reports in information amendments to the IND/IDE?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

33
Q

Who is responsible for submitting an annual report to the IND/IDE?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

34
Q

Who does the Clinical Investigator include?

A
  1. Investigator
  2. Any sub-investigators
  3. Spouse of investigator or sub-investigators
  4. Each dependent child of investigator or sub-investigator
35
Q

What is Form FDA 3454?

A

Certification: Financial Interests and Arrangements of Clinical Investigators

36
Q

What is Form FDA 3455?

A

Disclosure: Financial Interests and Arrangements of Clinical Investigators

37
Q

Who is responsible for registering an Applicable Clinical Trial (ACT)?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: a. sponsor

Explanation: A Principle Investigator (PI) can be responsible, however, this needs to be delegated by the sponsor.

38
Q

Who verifies the rights and well-being of human subjects are protected?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: b. monitor

39
Q

Who verifies reported trial data is accurate, complete and verifiable from source documents?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: b. monitor

40
Q

Who verifies the study is conducted in compliance with the study protocol, the GCP guidelines, and applicable regulations?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: b. monitor

41
Q

Who appoints a monitor for a clinical trial study?

A

a. sponsor
b. clerical staff
c. investigator
d. IRB

Correct answer: a. sponsor

42
Q

Who is properly trained and has the scientific and/or clinical knowledge needed to observe the trail adequately?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: b. monitor

43
Q

Who is the main line of communication between the sponsor and the investigator?

A

The monitor

44
Q

Who selects sites and/or processes for targeted for MVs?

A

The monitor

45
Q

What does the Statement of Investigator (1572) contain?

A
  1. The name and address of the investigational site(s)
  2. The name and address of the responsible IRB
  3. The name and address of clinical laboratories, if any
  4. For devices, the corresponding requirements are contained in an investigator’s agreement (no form comparable to Form FDA 1572)
46
Q

Who personally conducts or supervises the investigation?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

47
Q

Does the investigator need IRB approval prior to starting any study related activities?

A

Yes

48
Q

Who ensures that an IRB complies with requirements of 21 CFR 56 will be responsible for initial and continuing review?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

49
Q

Who promptly reports to the IRB all changes in the research activity and unanticipated problems?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

50
Q

Who does not may any changes in the research without the sponsor and IRB approval, except to eliminate hazards to human subjects?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

51
Q

Who conducts the study in accordance with the relevant, current protocol?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

52
Q

Who ensures requirements relating to obtaining informed consent (21 CFR 50) the IRB review and approval (21 CFR 56) are met?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

53
Q

Who obtains informed consent from each subject before entry into the study (ex. before any study related procedures)?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

54
Q

Who explains the proper use of the investigational product to subjects?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

55
Q

Who ensures proper storage and handling of study drug/device; accountability, return or destruction of unused study drug(s)?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

56
Q

Who informs subjects that study drugs are being used for investigational purposes?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

57
Q

Who ensures investigational product is used only by individuals who have agree to participate in clinical trials as evidenced by signed written informed consent?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

58
Q

Who assures the investigational product is used only by the investigator or qualified subinvestigators?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

59
Q

Who assures provisions of medical care be given to study patients for study related adverse events?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

60
Q

Per 21 CFR 312.64, who reports adverse events during the study?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

61
Q

Per 21 CFR 312.62, who maintains adequate and accurate records and make study records available for inspection?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

62
Q

How do you correct a mistake per GCP/ALCOA-C?

A

Single line through the error, enter correct information, initial and date change, provide explanation if needed; do not obliterate the the error, no erasures, no white-out.

63
Q

How do investigator’s verify the accountability records?

A
  1. Doses specified in the protocol were provided to subjects
  2. Drug/device was provided only to study subjects
  3. Use by study subjects reconciles the amounts received and returned to the sponsor
  4. Product was stored as specified by the sponsor and in compliance with applicable regulations
  5. Device was used for its intended purpose
64
Q

How often does the investigator needs to provide the IRB/IEC?

A

Annually or more frequent if required by the IRB/IEC

65
Q

Who does the final written summary to the IRB/IEC?

A

a. sponsor
b. monitor
c. investigator
d. IRB

Correct answer: c. investigator

66
Q

What does “clinical investigators” mean per 21 CFR 54?

A

Listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of research subjects”, including the spouse and each dependent child of the investigator or subinvestigator.

67
Q

How long is the investigator’s financial disclosure for compensation of >$25,000 or >$50,000 valid for?

A

a. 7 calendar days
b. 5 days
c. 1 year after completion of the study
d. year

Correct answer: c. 1 year after completion of the study

68
Q

How long is the investigator’s financial disclosure for compensation of any amount <$25,000 valid for?

A

a. 7 calendar days
b. 5 days
c. while the study is being conducted
d. year

Correct answer: c. while the study is being conducted

69
Q

What phase identifies potential new compounds?

A

a. pre-clinical/non-clinical
b. Phase I
c. Phase II
d. Post Market

Correct answer: a. pre-clinical/non-clinical

70
Q

What phase tests in appropriate laboratory and animal models to assess potential activity in humans?

A

a. pre-clinical/non-clinical
b. Phase I
c. Phase II
d. Post Market

Correct answer: a. pre-clinical/non-clinical

71
Q

What phase involves thousands of molecules?

A

a. pre-clinical/non-clinical
b. Phase I
c. Phase II
d. Post Market

Correct answer: a. pre-clinical/non-clinical

72
Q

What phase develops the dosage forms?

A

a. pre-clinical/non-clinical
b. Phase I
c. Phase II
d. Post Market

Correct answer: a. pre-clinical/non-clinical

73
Q

What phase includes animal models?

A

a. pre-clinical/non-clinical
b. Phase I
c. Phase II
d. Post Market

Correct answer: a. pre-clinical/non-clinical

74
Q

What needs to occur prior to a clinical trial beginning? 3 things.

A
  1. summaries of all acute toxicity studies
  2. 28-day studies in one rodent and one non-rodent species, usually rats and dogs
  3. regulatory authorities can require more information
  4. non-clinical studies have to support the conclusion that the drug can be administered safely to human subjects
75
Q

What phase helps to assure the quality of the scientific evaluation is adequate to permit evaluation of the drug’s safety and effectiveness?

A

a. pre-clinical/non-clinical
b. Phase I
c. Phase II
d. Post Market

Correct answer: b. Phase II

76
Q
A

SOCRA 2024 (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions